Real world data using sacubitril/valsartan in CKD stage 4 and 5 is associated with improved ejection fraction and may have renoprotective effects.
11 May 2024 (08:00 - 20:00)
Organised by: 
About the speaker
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
7 More presentations in this session
Miss H. Hauksdottir (Reykjavik, IS)
Doctor S. Zhou (Toronto, CA)
Doctor I. Isaia (Rochester, US)
Associate Professor M. Zdravkovic (Belgrade, RS)
Access the full session
The Event
Heart Failure 2024
11 May - 14 May 2024
